YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Bora to manufacture and package clinical trial drug product for JAQBO tablets as Onconic advances U.S. Phase 3 preparation for gastroesophageal reflux disease (GERD) MAPLE GROVE, Minn., July 23, 2026--(BUSINESS WIRE)--Bora Pharmaceuticals…
Transaction Valued at $122.5M Establishes 20,000-Liter US Biologics Drug Substance Manufacturing Platform, Covering Development through Commercial Supply TAIPEI, TAIWAN / ACCESS Newswire / July 2, 2026 / Bora Pharmaceuticals Co., Ltd. ("Bo…
MAPLE GROVE, Minn., May 20, 2026 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX), today announced the recent launch of Cyclosporine Ophthalmic Emulsion…
medical research 8 ©PickPik MacroGenics agreed to sell its GMP manufacturing operations to Bora Pharmaceuticals in a deal designed to strengthen its balance sheet and sharpen focus on its oncology pipeline. Key Investor Takeaways MacroGeni…
•MacroGenics to receive $122.5 million upfront payment from Bora upon closing •Transaction includes transfer of manufacturing site, CDMO operations and associated personnel to Bora ROCKVILLE, MD, May 11, 2026 (GLOBE NEWSWIRE) -- MacroGenic…
MacroGenics, Inc. •MacroGenics to receive $122.5 million upfront payment from Bora upon closing •Transaction includes transfer of manufacturing site, CDMO operations and associated personnel to Bora ROCKVILLE, MD, May 11, 2026 (GLOBE NEWSW…
Caregiver and Healthcare Professional Platforms Provide Resources for Initiating and Managing KYMBEE™ (deflazacort) Tablets Treatment MAPLE GROVE, Minn., April 14, 2026 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsi…
First Prescription Ear Drop Suspension Advances Portfolio Diversification Strategy MAPLE GROVE, Minn., April 6, 2026 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and…
Virtual Investor Conferences The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences…
(RTTNews) - Bora Pharmaceuticals Co., Ltd. (6472.TW, BORAY), a Taiwan-based international pharmaceutical company, on Monday announced a renewed five-year manufacturing partnership with a pharmaceutical and biotechnology company, GSK plc (G…
Bora manufactures more than 20 commercial products for GSK at its Mississauga facility, supporting infectious disease, mental health, dermatology, & other critical therapeutic areas MISSISSAUGA, Ontario, February 23, 2026--(BUSINESS WIRE)-…
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bora Pharmaceuticals Co., Ltd. (TWSE: 6472; OTCQX: BORAY)…
OTC Markets NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bora Pharmaceuticals Co., Ltd. (TWSE: 6472; O…